Blood clot concerns linked to the Oxford vaccine will be addressed by the UK’s drugs watchdog at a news conference this afternoon.
The briefing, together with the Joint Committee on Vaccination and Immunisation (JCVI), will be held at the Department of Health at 3pm.
England’s deputy chief medical officer Professor Jonathan Van-Tam will be among those attending, along with Dr June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA) and JCVI chairman Professor Wei Shen.
The MHRA confirmed that of those 30 people, seven had died as of 24 March.
Will Oxford jab concerns derail UK vaccine rollout?
But the drugs watchdog maintained there was no evidence to suggest a causal link between the rare blood clots and the Oxford jab, and that the benefits continue to outweigh any risk.
The same message has been echoed by ministers.
The EU’s medical regulator is also expected to announce the findings of its own review into the jab, after several European nations paused rollout of the vaccine to younger people, following reports of the condition that prevents blood draining from the brain.
It comes after the head of the European Medicines Agency’s (EMA) head of vaccine strategy said it was “increasingly difficult” to say there is “no cause and effect relationship” between the Oxford jab and “rare cases of unusual blood clots”.
However, Marco Cavaleri added that full evaluation work was still “far from being completed” and that the risk-benefit ratio was still in favour of the vaccine.
I am a highly skilled IT Specialist with over 12 years of experience in Web Design, Graphic Design, Web Blogging, ITL Management, IT Support Desk Manager Skills. I am a qualified and experienced within NHS, Automotive Companies, HR, Administration, Finance, marketing and other 3rd Party Companies with IT requirements. I am also self employed as Web Design, Radio Broadcaster, Media Technician, Sound Engineer and IT Specialist.